Customized Antibody Generation for Therapeutics and Diagnostics Research Applications

Antibodies are crucial tools in scientific research and in recent years, act as diagnostic tool and a therapeutic mean to many diseases. The earliest reference of antibodies generation was in 1890 from Emil von Behring and Shibasabura Kitasato, in which, they showed in their landmark paper, the transfer of serum from immunized animals to cure infected animals. Since then, much research has been done, with the invention of monoclonal antibodies in 1975 by Georges Köhler and César Milstein to signal the start of the modern era of antibody research and discovery. Despite the many years of research and efforts in optimizing the art of antibody generation, production of antibodies is still often labor intensive and risky due to the possibilities of various variables introduced during the course of antibody production. As such, selecting the right experimental approach early on is critical in successfully producing the antibody.

In this webinar, we will cover

How to choose the between polyclonal and monoclonal antibodies that is right for your application.

The technologies available to ensure success in generating antibodies, in particular, monoclonal antibodies.

The different antibody applications in research, diagnostic and therapeutics as demonstrated by various case studies.

In this webinar, you will learn

Webinar Details

  • Date: 22nd April, 2021
  • Time: 10 AM SGT
  • Speaker:
David Wood, Ph.D. Dr. Howwing Leung

Field Application Scientist, GenScript

How Wing Leung, Ph.D. is the Field Application Scientist, supporting the protein expression and antibody production services at GenScript. Dr. Leung graduated from the National University of Singapore in 2011, majoring in Pharmacology and Neuroscience and worked as a research fellow in Duke-NUS Medical School thereafter. She has more than 10 years of research experience in molecular biology techniques and extensive knowledge in protein structure modelling, protein expression and its purification. Using these platforms, she deciphered novel cleavage site of proteases and their functional implications in stroke upon cleavage of the ionotropic glutamate receptor.

Related Products and Services

Speaker-related Webinars

Speaker-related Webinars